Aina He

4.5k citations
83 papers · 2.8k indexed · h-index 32

Impact in

Papers in

Aina He

80 papers receiving 2.7k citations

Peers

Aina He
Comparison fields: 5 of 115
  • Oncology 891
  • Cancer Research 405
  • Genetics 250
  • Immunology 485
  • Pulmonary and Respiratory Medicine 749
Replace Marie‐Françoise Heymann with:
Marie‐Françoise Heymann France
Mitsunori Yamakawa Japan
David Lagares United States
Bang H. Hoang United States
John Slavin Australia
Aki Yoshida Japan
Shogo Katsuda Japan
Sonsoles Piera-Velázquez United States
Bin Feng China
Aina He relative to Marie‐Françoise Heymann France Marie‐Françoise Heymann's profile →
Citations per field
00.5×1.5×
Marie‐Françoise Heymann · 1×
Citations per year

Countries citing papers authored by Aina He

Since Specialization
Citations

This map shows the geographic impact of Aina He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aina He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aina He more than expected).

Fields of papers citing papers by Aina He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aina He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aina He. The network helps show where Aina He may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aina He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aina He Line = papers co-authored together Aina He links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20254
3 20250
4 202343
5 202212
6 20212
7 202030
8 201967
9 201923
10 201913
11 2018102
12 201824
13 201647
14 201520
15 201337
16 201328
17 201241
18 201245
19 201229
20
COX proportional-hazard regression analysis of prognostic factors in 52 adult patients with osteosarcoma
20111

About Aina He

Aina He is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Rheumatology, having authored 83 papers that have together received 2.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Cells and Metastasis (9 papers), Bone Tumor Diagnosis and Treatments (8 papers), Mast cells and histamine (7 papers), Mesenchymal stem cell research (6 papers), Lung Cancer Research Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (891 citations), Cancer Research (405 citations), Genetics (250 citations), Immunology (485 citations) and Pulmonary and Respiratory Medicine (749 citations). Aina He has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Zan Shen, Yang Yao, Wei‐Xiang Qi, Lina Tang, Yuanjue Sun, Guo‐Ping Shi, Feng Lin, Yujing Huang, Daliu Min and Jianan Wang. Their work appears in journals such as PLoS ONE, Journal of Zhejiang University SCIENCE B, Current Medical Research and Opinion, Annals of Oncology and Lung.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026